How to Become an Angel Kings Investor.
To begin investing in America's hottest startups, we must first verify that you are an accredited investor.
Only accredited investors will gain access to the hottest investment funds before they go public as an IPO.
The majority of our venture capital (97% percent) is devoted to our own “Design and Build” startup program. This means that we not only design and build startups, but we also prepare startups to reach Series A, B, C and IPO funding.
Through Angel Kings, we personally vet every startup because each of them have to apply and get accepted to our startup build program.
Verify You are an Accredited Investor
How do we select the top startups for our startup build program?
Answer: We select less than 1% of the startups that apply to be part of our design, build, and launch program for startups. If you are a startup, get in touch to see if you qualify.
Many angel investors have favorite sectors, and some sectors lend themselves to angel investing. Software or Internet services require less capital than manufacturing startups, for example, which means large venture capitalists aren't always required for seed and series rounds.
Single founders or co–founders are also more likely to approach angel investors, and many of those individuals are currently working in tech–based fields.
Here are just some examples of the types of startup technologies we are creating in the next 5 years:
E-Commerce: we build websites, mobile apps and software that have the capacity for billions of users.
Big Data: our data scientists and engineers focus on scaling startups from zero users to potentially billions.
Mobile apps: our mobile apps are designed and built to capture the App store and Google Play store “Top 5” list. Meaning, we don’t design or build unless we are certain we can build the best.
Custom software: our software engineers also build custom software for Salesforce, Google Cloud, Amazon Web Services, and some of the most popular SaaS and CRM programs in the World.
Examples of startups we have successfully built…
Protecting Hospitals, Patients, and Physicians from Cyber-attacks.
Our cybersecurity venture capital fund is geared towards protecting medical facilities, patient data, and hospitals from cyber-attacks.
As of early 2018/2019, there were more than 220 cybersecurity startups in America with an average valuation of $4.7 million. Such startups are attractive to investors for a variety of reasons, not the least of which is a general high potential for IPO and acquisition events for any small company in the industry. Cybersecurity startups make good investments is that the best companies tend to scale up quickly. Tech firms in general are experts at building on existing technology; they rarely start from scratch, letting then bring viable products to market in short time spans. Because those products tend to meet an urgent psychological and actual need for users, an apt marketing campaign or integration is often all it takes for good products to find sales success.
TOP BIG DATA STARTUPS
Protecting Big Data within Hospitals, Medical Research Facilities, Universities, and Private Practices.
Angel Kings has design, launched and built some of America’s best big data startups.
Big Data is an interesting sector for investors because you don't have to stay within the business and software scope. A number of startups are bringing mobile–to–consumer applications into the data space, and with so many consumers seeking to organize and order their lives, these companies are seeing success. One interesting startup, which has garnered $8 million in funding since 2010, is Yummly. The startup piggybacks preference–based delivery ideas offered by products such as Netflix and Pandora, but applies those ideas to food.
HOTTEST BIOTECH STARTUPS
We invest in the future of medicine vis-a-vis Drug Discovery, Cancer Research, and Brain Medicine.
Angel Kings has served an integral part in designing, building, and launching some of America’s top biotech startups.
“Biotech”, or biotechnology, includes the field of all startups that are biology–based technology companies. Some types of companies in the field include pharmaceutical companies, R&D firms with a biological focus, and equipment and tech firms servicing research labs and scientists. The combined purpose of most of these companies is to develop knowledge, technology, and products that fight diseases or provide solutions for other global issues such as hunger or resource scarcity.
As with cybersecurity, biotech startups offer a good chance at IPO action. In 2013, the industry saw more IPOs overall than it had for the past 13 years. While the industry is more volatile overall than other options, no one will argue that biotech will continue to be relevant through 2020, and many biotech firms offer long–term investment opportunities that can balance out the portfolios of angel investors with a lot of hot–burning software investments. Learn more about one of our favorite Biotech startups in this video!